Summary

Persistence Market Research has recently released a detailed report on the global Clinical Communication and Collaboration (CC&C) market, offering a thorough analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This report provides in-depth insights into the market structure and its future trajectory.

Key Insights:

• Clinical Communication and Collaboration Market Size (2024E): USD 2540 Mn
• Projected Market Value (2033F): USD 5259.8 Mn
• Global Market Growth Rate (CAGR 2024 to 2033): 8.4%

Clinical Communication and Collaboration Market - Report Scope:

The Clinical Communication and Collaboration market is gaining momentum due to the increasing demand for efficient and integrated communication solutions within healthcare settings. These solutions are designed to enhance coordination among healthcare professionals, streamline patient care, and boost overall operational efficiency. Market growth is driven by the need for advanced communication tools that facilitate real-time information sharing, reduce clinical errors, and support decision-making in healthcare environments.

Market Growth Drivers:

Several key factors are fueling the growth of the Clinical Communication and Collaboration market. The widespread adoption of electronic health records (EHR) and other digital health technologies is driving demand for integrated communication systems that connect various healthcare stakeholders seamlessly. Enhancing patient outcomes, improving workflow efficiency, and ensuring regulatory compliance are major drivers behind increased investment in CC&C solutions. Additionally, the rising emphasis on telemedicine and remote patient monitoring further contributes to market expansion, as these solutions require effective communication platforms to function optimally.

Market Restraints:

Despite its growth potential, the Clinical Communication and Collaboration market faces several challenges. High implementation and maintenance costs of advanced communication systems can be a barrier, particularly for smaller healthcare providers. Concerns about data security and privacy, given the sensitive nature of healthcare information, also present significant challenges. Furthermore, integrating new CC&C solutions with existing healthcare IT infrastructure can be complex and time-consuming, potentially hindering market growth.

Market Opportunities:

The Clinical Communication and Collaboration market offers numerous growth opportunities. Technological advancements, including the integration of artificial intelligence (AI) and machine learning (ML) capabilities, are enhancing the functionality of communication solutions and driving market expansion. The growing adoption of cloud-based solutions provides flexibility and scalability, facilitating easier implementation and management of CC&C systems. Strategic partnerships between technology providers and healthcare institutions, along with expansion into emerging markets, present substantial opportunities for growth.

Key Questions Answered in the Report:

• What are the primary factors driving the global Clinical Communication and Collaboration market?
• Which healthcare segments are showing the highest adoption of CC&C solutions, and which regions are leading in this adoption?
• How are advancements in technology influencing the competitive landscape of the CC&C market?
• Who are the leading players in the Clinical Communication and Collaboration market, and what strategies are they using to maintain their market positions?
• What are the emerging trends and future prospects in the global Clinical Communication and Collaboration market?

Competitive Intelligence and Business Strategy:

Leading players in the Clinical Communication and Collaboration market, such as Vocera Communications, TigerText, and Philips Healthcare, are concentrating on innovation and strategic partnerships to maintain their competitive edge. These companies are investing in research and development to enhance their communication solutions' capabilities and address the evolving needs of the healthcare industry. Forming strategic alliances with healthcare providers and continuously improving product offerings are crucial for market penetration and sustained success. Addressing challenges related to cost, integration, and data security is essential for market players to achieve long-term growth and leadership in the Clinical Communication and Collaboration market.

Key Companies Profiled:

• Vocera Communications
• TigerConnect
• Intelligent Business Communication – AGNITY
• Cisco Systems Inc.
• Jive Software
• Microsoft Corporation
• Everbridge
• PerfectServe, Inc.
• Uniphy Health Systems LLC
• UDG Healthcare PLC
• Ascom
• NEC Corporation
• Spok Inc.
• Voalte

Key Segments of Clinical Communication and Collaboration Market Research

By Component:

• Clinical Communications and Collaboration Hardware
• Clinical Communications and Collaboration Software
• Clinical Communications and Collaboration Services

By Content Type:

• Text Clinical Communications and Collaboration
• Video Clinical Communications and Collaboration
• Voice Clinical Communications and Collaboration

By End User:

• Clinical Communications and Collaboration for Clinical Labs
• Clinical Communications and Collaboration for Hospitals
• Clinical Communications and Collaboration for Physicians
• Clinical Communications and Collaboration for Hotels
• Clinical Communications and Collaboration for Retail
• Clinical Communications and Collaboration for Correctional Facilities

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• Middle East and Africa (MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Pricing Analysis
4.1. Pricing Analysis, By Component
4.1.1. Hardware Pricing Analysis
4.1.2. Software Pricing Analysis
4.2. Average Pricing Analysis Benchmark
5. Global Clinical Communication and Collaboration Market Demand (Value in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031
5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors - Relevance & Impact
6.3. Value Chain
6.4. COVID-19 Crisis -; Impact Assessment
6.4.1. Current Statistics
6.4.2. Short-Mid-Long Term Outlook
6.4.3. Likely Rebound
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.5.3. Opportunities
7. Global Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031, By Component
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Component, 2019-2023
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2024-2031
7.3.1. Clinical Communications and Collaboration Hardware
7.3.1.1. Clinical Communications and Collaboration through Mobiles/Tablets
7.3.1.2. Clinical Communications and Collaboration through Pagers
7.3.1.3. Clinical Communications and Collaboration through Access Points
7.3.1.4. Others
7.3.2. Clinical Communications and Collaboration Software
7.3.2.1. Clinical Communications and Collaboration for Secure Messaging
7.3.2.2. Clinical Communications and Collaboration for Workflow Management
7.3.2.3. Clinical Communications and Collaboration for User Management
7.3.2.4. Others
7.3.3. Clinical Communications and Collaboration Services
7.3.3.1. Clinical Communications and Collaboration for Support and Maintenance
7.3.3.2. Clinical Communications and Collaboration for Integration
7.3.3.3. Clinical Communications and Collaboration for Training
7.4. Market Attractiveness Analysis By Component
8. Global Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031, By Content Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Power Device, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Power Device, 2024-2031
8.3.1. Text Clinical Communications and Collaboration
8.3.2. Video Clinical Communications and Collaboration
8.3.3. Voice Clinical Communications and Collaboration
8.4. Market Attractiveness Analysis by Power Device
9. Global Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
9.3.1. Clinical Communications and Collaboration for Clinical Labs
9.3.2. Clinical Communications and Collaboration for Hospitals
9.3.3. Clinical Communications and Collaboration for Physicians
9.3.4. Clinical Communications and Collaboration for Hotels
9.3.5. Clinical Communications and Collaboration for Retail
9.3.6. Clinical Communications and Collaboration for Correctional Facilities
9.3.7. Others
9.4. Market Attractiveness Analysis By End User
10. Global Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031, By Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2031
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia Pacific
10.3.6. Middle East and Africa
10.4. Market Attractiveness Analysis by Region
11. North America Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
11.3.1. By Component
11.3.2. By Content Type
11.3.3. By End User
11.3.4. By Country
11.3.4.1. U.S.
11.3.4.2. Canada
11.4. Market Attractiveness Analysis
11.4.1. By Component
11.4.2. By Content Type
11.4.3. By End User
11.4.4. By Country
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
12. Latin America Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
12.3.1. By Component
12.3.2. By Content Type
12.3.3. By End User
12.3.4. By Country
12.3.4.1. Brazil
12.3.4.2. Mexico
12.3.4.3. Rest of Latin America
12.4. Market Attractiveness Analysis
12.4.1. By Component
12.4.2. By Content Type
12.4.3. By End User
12.4.4. By Country
13. Europe Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
13.3.1. By Component
13.3.2. By Content Type
13.3.3. By End User
13.3.4. By Country
13.3.4.1. Germany
13.3.4.2. Italy
13.3.4.3. France
13.3.4.4. U.K.
13.3.4.5. Spain
13.3.4.6. BENELUX
13.3.4.7. Russia
13.3.4.8. Rest of Europe
13.4. Market Attractiveness Analysis
13.4.1. By Component
13.4.2. By Content Type
13.4.3. By End User
13.4.4. By Country
14. South Asia & Pacific Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
14.3.1. By Component
14.3.2. By Content Type
14.3.3. By End User
14.3.4. By Country
14.3.4.1. India
14.3.4.2. Indonesia
14.3.4.3. Malaysia
14.3.4.4. Singapore
14.3.4.5. Australia & New Zealand
14.3.4.6. Rest of South Asia and Pacific
14.4. Market Attractiveness Analysis
14.4.1. By Component
14.4.2. By Content Type
14.4.3. By End User
14.4.4. By Country
15. East Asia Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
15.3.1. By Component
15.3.2. By Content Type
15.3.3. By End User
15.3.4. By Country
15.3.4.1. China
15.3.4.2. Japan
15.3.4.3. South Korea
15.4. Market Attractiveness Analysis
15.4.1. By Component
15.4.2. By Content Type
15.4.3. By End User
15.4.4. By Country
16. Middle East and Africa Clinical Communication and Collaboration Market Analysis 2019-2023 and Forecast 2024-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
16.3.1. By Component
16.3.2. By Content Type
16.3.3. By End User
16.3.4. By Country
16.3.4.1. GCC Countries
16.3.4.2. Turkey
16.3.4.3. South Africa
16.3.4.4. Rest of Middle East and Africa
16.4. Market Attractiveness Analysis
16.4.1. By Component
16.4.2. By Content Type
16.4.3. By End User
16.4.4. By Country
17. Key Countries Analysis- Clinical Communication and Collaboration Market
17.1. U.S. Clinical Communication and Collaboration Market Analysis
17.1.1. By Component
17.1.2. By Content Type
17.1.3. By End User
17.2. Canada Clinical Communication and Collaboration Market Analysis
17.2.1. By Component
17.2.2. By Content Type
17.2.3. By End User
17.3. Mexico Clinical Communication and Collaboration Market Analysis
17.3.1. By Component
17.3.2. By Content Type
17.3.3. By End User
17.4. Brazil Clinical Communication and Collaboration Market Analysis
17.4.1. By Component
17.4.2. By Content Type
17.4.3. By End User
17.5. Germany Clinical Communication and Collaboration Market Analysis
17.5.1. By Component
17.5.2. By Content Type
17.5.3. By End User
17.6. Italy Clinical Communication and Collaboration Market Analysis
17.6.1. By Component
17.6.2. By Content Type
17.6.3. By End User
17.7. France Clinical Communication and Collaboration Market Analysis
17.7.1. By Component
17.7.2. By Content Type
17.7.3. By End User
17.8. U.K. Clinical Communication and Collaboration Market Analysis
17.8.1. By Component
17.8.2. By Content Type
17.8.3. By End User
17.9. Spain Clinical Communication and Collaboration Market Analysis
17.9.1. By Component
17.9.2. By Content Type
17.9.3. By End User
17.10. BENELUX Clinical Communication and Collaboration Market Analysis
17.10.1. By Component
17.10.2. By Content Type
17.10.3. By End User
17.11. Russia Clinical Communication and Collaboration Market Analysis
17.11.1. By Component
17.11.2. By Content Type
17.11.3. By End User
17.12. Rest of Europe Clinical Communication and Collaboration Market Analysis
17.12.1. By Component
17.12.2. By Content Type
17.12.3. By End User
17.13. China Clinical Communication and Collaboration Market Analysis
17.13.1. By Component
17.13.2. By Content Type
17.13.3. By End User
17.14. Japan Clinical Communication and Collaboration Market Analysis
17.14.1. By Component
17.14.2. By Content Type
17.14.3. By End User
17.15. South Korea Clinical Communication and Collaboration Market Analysis
17.15.1. By Component
17.15.2. By Content Type
17.15.3. By End User
17.16. India Clinical Communication and Collaboration Market Analysis
17.16.1. By Component
17.16.2. By Content Type
17.16.3. By End User
17.17. Malaysia Clinical Communication and Collaboration Market Analysis
17.17.1. By Component
17.17.2. By Content Type
17.17.3. By End User
17.18. Indonesia Clinical Communication and Collaboration Market Analysis
17.18.1. By Component
17.18.2. By Content Type
17.18.3. By End User
17.19. Singapore Clinical Communication and Collaboration Market Analysis
17.19.1. By Component
17.19.2. By Content Type
17.19.3. By End User
17.20. Australia and New Zealand Clinical Communication and Collaboration Market Analysis
17.20.1. By Component
17.20.2. By Content Type
17.20.3. By End User
17.21. GCC Countries Clinical Communication and Collaboration Market Analysis
17.21.1. By Component
17.21.2. By Content Type
17.21.3. By End User
17.22. Turkey Clinical Communication and Collaboration Market Analysis
17.22.1. By Component
17.22.2. By Content Type
17.22.3. By End User
17.23. South Africa Clinical Communication and Collaboration Market Analysis
17.23.1. By Component
17.23.2. By Content Type
17.23.3. By End User
17.24. Rest of Middle East and Africa Clinical Communication and Collaboration Market Analysis
17.24.1. By Component
17.24.2. By Content Type
17.24.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Vocera Communications
19.3.1.1. Business Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Business Segments/Region)
19.3.1.4. Key Strategy & Developments
19.3.2. TigerConnect
19.3.2.1. Business Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Business Segments/Region)
19.3.2.4. Key Strategy & Developments
19.3.3. Intelligent Business Communication -; AGNITY
19.3.3.1. Business Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Business Segments/Region)
19.3.3.4. Key Strategy & Developments
19.3.4. Cisco Systems Inc.
19.3.4.1. Business Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Business Segments/Region)
19.3.4.4. Key Strategy & Developments
19.3.5. Jive Software
19.3.5.1. Business Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Business Segments/Region)
19.3.5.4. Key Strategy & Developments
19.3.6. Microsoft Corporation
19.3.6.1. Business Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Business Segments/Region)
19.3.6.4. Key Strategy & Developments
19.3.7. Everbridge
19.3.7.1. Business Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Business Segments/Region)
19.3.7.4. Key Strategy & Developments
19.3.8. PerfectServe, Inc.
19.3.8.1. Business Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Business Segments/Region)
19.3.8.4. Key Strategy & Developments
19.3.9. Uniphy Health Systems LLC
19.3.9.1. Business Overview
19.3.9.2. Product Portfolio
19.3.9.3. Profitability by Market Segments (Business Segments/Region)
19.3.9.4. Key Strategy & Developments
19.3.10. UDG Healthcare PLC
19.3.10.1. Business Overview
19.3.10.2. Product Portfolio
19.3.10.3. Profitability by Market Segments (Business Segments/Region)
19.3.10.4. Key Strategy & Developments
19.3.11. Ascom
19.3.11.1. Business Overview
19.3.11.2. Product Portfolio
19.3.11.3. Profitability by Market Segments (Business Segments/Region)
19.3.11.4. Key Strategy & Developments
19.3.12. NEC Corporation
19.3.12.1. Business Overview
19.3.12.2. Product Portfolio
19.3.12.3. Profitability by Market Segments (Business Segments/Region)
19.3.12.4. Key Strategy & Developments
19.3.13. Spok Inc.
19.3.13.1. Business Overview
19.3.13.2. Product Portfolio
19.3.13.3. Profitability by Market Segments (Business Segments/Region)
19.3.13.4. Key Strategy & Developments
19.3.14. Voalte
19.3.14.1. Business Overview
19.3.14.2. Product Portfolio
19.3.14.3. Profitability by Market Segments (Business Segments/Region)
19.3.14.4. Key Strategy & Developments
20. Assumptions and Acronyms Used
21. Research Methodology